Drug policy: making effective drugs available without bankrupting the healthcare system
Laupacis A, Anderson G, O'Brien B. Healthc Pap. 2002; 3(1):12-30.
Publications
Hospital Funding for New Drug Technologies
Dissemination of discharge summaries. Not reaching follow-up physicians
van Walraven C, Seth R, Laupacis A. Can Fam Physician. 2002; 48(4):737-42.
Prostate-specific Antigen (PSA) Screening in Asymptomatic Men
Effect of discharge summary availability during post-discharge visits on hospital readmission
van Walraven C, Seth R, Austin PC, Laupacis A. J Gen Intern Med. 2002; 17(3):186-92.
Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?
Laupacis A. CMAJ. 2002; 166(1):44-7.
How well is the clinical importance of study results reported? An assessment of randomized controlled trials
Chan KB, Man-Son-Hing M, Molnar FJ, Laupacis A. CMAJ. 2001; 165(9):1197-202.
The future of evidence-based medicine
Laupacis A. Can J Clin Pharmacol. 2001; 8(Suppl A):6A-9A.
Use of statins and the subsequent development of deep vein thrombosis
Ray JG, Mamdani MM, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Arch Intern Med. 2001; 161(11):1405-10.